Infographic: Overview of the CAR-T cell therapy workflow

Find out more about the CAR-T cell therapy workflow in this informative infographic from Bio-Rad Laboratories (CA, USA). Discover some of the challenges associated with CAR-T cell R&D as well as technologies and reagents used for bioanalytical analysis.

CAR-T cell therapy has been referred to as a ‘living drug’, as the genes incorporated not only signal the T cells to attack and destroy cancer cells, but also to grow and proliferate. This means that a patient may only need to be treated once, reducing discomfort and time required to fulfill traditional treatment strategies. CAR-T is also cancer-cell specific, which reduces side effects associated with the destruction of healthy cells experienced with chemotherapy and radiation.